CellSine

Andreas Vesaliusstraat 5 B301

3000 Leuven

BE

CellSine

Foundation date

11-2015

Sector

#Biotechnology / R&D Services

Subsector

CellSine was founded in 2015 as a spin-off company from KU Leuven and VUB. We offer instruments and services based on advanced electrochemical impedance spectroscopy for drug discovery and other biomedical applications. The proprietary I-series devices allow you to perform broad-spectrum impedance measurements. Such measurements enable the detection of a wide range of biological phenomena without the use of chemical labels.The latter aspect enables you to design your own high content analyses of living cells in a matter of weeks. The “light” structure of the resulting “big”data is ideal for ultimate exploration with artificial intelligence methods, machine learning, and many other data processing tools.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    23 hours ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    23 hours ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    23 hours ago